Healthcare Business Review
About UsConferencePartner With Us
  • Patient Care
    Medical Transportation
    Plastic Surgery
    Regenerative Medicine
    Therapy Services 
  • Operations
    Consulting Service
    Digital Transformation
    Financial Services
    Healthcare Insurance
    Healthcare Marketing
    Healthcare Outsourcing
    Healthcare Staffing
    Medical Billing
  • Healthcare Services
    Facility Management Services
    Healthcare Education
    Healthcare Procurement
  • Leadership Perspectives
  • Insights
  • News
  • Magazines
    • APAC
      • US
      • EUROPE
      • APAC
      • CANADA
      • LATAM
×
#

Healthcare Business Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Healthcare Business Review

Subscribe

loading

Thank you for Subscribing to Healthcare Business Review Weekly Brief

AI and First-Party Data Transforms Pharma Customer Engagement

Conversational AI and other virtual assistants encourage bottom-of-funnel engagement by giving healthcare professionals access to information they would be reluctant to ask representatives for. 

By

Healthcare Business Review | Friday, January 31, 2025

AI in healthcare enhances engagement, streamlines data collection and improves patient access. Pharma must ensure compliance and build trust through transparent, patient-centric DTC models while adapting to evolving consumer needs and technology integration.


FREMONT, CA: Conversational AI and other virtual assistants encourage bottom-of-funnel engagement by giving healthcare professionals access to information they would be reluctant to ask representatives for. It's crucial to align incentive programs and ensure sales representatives comprehend AI's long-term benefits. Extensive testing is also crucial to guarantee AI technologies are precise and compliant, particularly when interacting with patients and healthcare professionals.


It improves data collection and offers insightful information. First-party data helps comprehend and interact with customers. Platforms for real-time consumer data enable businesses to modify their marketing strategies in response to healthcare professional behavior. Aligning brand objectives with customer experiences is crucial for successful AI integration.

Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.


Compared to IT businesses, pharma's use of AI is subject to more scrutiny, underscoring the need for a more careful and open approach. AI is essential for growing customer engagement, and healthcare professionals are using it more efficiently. Younger healthcare professionals desire quick, self-service access to information.


While conversational AI helps brands react more quickly and remain competitive by enhancing the patient experience, this model gives patients more control over their therapies. Accelerating access to therapies is the challenge. Pharma may satisfy changing consumer demands by concentrating on AI and patient-direct models, particularly for people with long commutes or working mothers who lack the time or access to traditional healthcare services.


Direct-to-consumer (DTC) platforms are completely changing how pharmaceutical businesses interact with their patients by providing easier links to providers, reducing the product procurement cycle, and improving the overall customer experience. Building personal connections with patients is necessary to expedite access to therapies, from obtaining samples to filling prescriptions and delivering them to their homes.


The pandemic has greatly raised patient confidence in telehealth services. Patients now depend on telehealth physicians to deliver care comparable to that of their traditional medical providers.


The success of DTC models relies on establishing and preserving trust. Leveraging such technology is necessary to improve communication and guarantee access for all patient groups. When pharma assesses the suitability of conversational AI for various patient groups, it's critical to take into account how patients traverse information and ensure that the solutions are noticeably superior to current ones.


Even though AI can enhance experiences, it won't be able to address every problem at once. Therefore, success requires a thorough and candid evaluation of its worth.


More in News

Healthcare Market Research Firms Supporting Growth And Innovation In Europe

The healthcare industry is constantly developing due to changing patient needs, technological advancements, regulatory developments, and shifting market dynamics. Healthcare organisations, including pharmaceutical companies, medical device manufacturers, healthcare providers, biotechnology firms, and healthcare technology companies, require accurate market intelligence to make informed business decisions. Healthcare market research firms provide valuable insights into industry trends, customer behaviour, competitive landscapes, and emerging opportunities. Through data collection, analysis, and strategic reporting, these firms help organisations reduce uncertainty, improve decision-making, and support sustainable growth in an increasingly complex healthcare environment across Europe. Understanding Healthcare Trends through Comprehensive Market Research Insights Healthcare market research companies are essential for assisting organisations to understand the market and developments in the healthcare industry. The healthcare industry is affected by a variety of factors, such as demographic shifts, healthcare policies, technological advancements, patient expectations, and economic conditions. Organisations can track these trends and gain insights into opportunities or challenges through market research. Research often involves gaining information from healthcare professionals, patients, payers, healthcare administrators, and industry stakeholders. Research companies collect valuable data, which can be used in evidence-based decision-making, by conducting surveys, interviews, focus groups, and analysing data. Segmentation in the healthcare market is also a significant part of healthcare research. It is important for organisations to know the attributes, tastes and demands of various groups of customers. The identification of specific segments enables the companies to design specific products, services and marketing strategies, which are more appropriate to the needs of the customer. Competitive intelligence is also a major part of the healthcare market research. Competitor activity and product launches, pricing, market positioning and industry performance are all considered. These insights give insight into competitive dynamics and develop effective business strategies across Europe. Market research companies in the healthcare sector also assess new technologies and innovations. The industry is continually changing, with new treatments, digital health solutions, medical devices, and models of healthcare delivery all impacting it. Research aids organisations in gauging the readiness of the market, the potential for adoption, and future growth opportunities related to these developments. Supporting Product Development and Strategic Business Decisions Effectively Healthcare organisations often use market research as a tool for product development and business planning. To design new healthcare products or services, it is important to know what customers expect, what clinical needs are being addressed, market demand and competitive landscape. Healthcare market research firms enable companies to gauge the unmet needs in the market. Competitors can identify gaps in current products and services, creating solutions that address the specific needs of healthcare providers, patients, and other stakeholders. Product concept testing is another valuable research activity. Organisations can check the viability of ideas they consider for the product by testing them with their customers and in the market before investing in the product's development. These insights decrease the chances of development risks and enhance the probability of market acceptance. Developing a pricing strategy may often require extensive market research. By having insights into customer perceptions, reimbursement factors, competitor pricing, and market dynamics, organisations can set up pricing strategies that are both profitable and market-friendly. Reliable data and objective analysis are essential for strategic decision-making. Healthcare market research firms help leadership teams make informed decisions based on evidence-based data and insights, which drive investment, partnerships, expansion, and resource allocation decisions. These insights help to enhance business strategies and organisational performance. Long-Term Growth through Data-Driven Market Intelligence Solutions For organisations to be successful over time in the healthcare industry, they must be able to adjust to market dynamics. Healthcare market research firms offer real-time insights that enable businesses to stay one step ahead of the curve and react to market trends and customer needs. “By having insights into customer perceptions, reimbursement factors, competitor pricing, and market dynamics, organisations can set up pricing strategies that are both profitable and market-friendly.” Forecasting and trend analysis are important components of market intelligence. Research firms analyse past trends, present market conditions and new developments to help inform their view on possible future opportunities and threats. Such insights enable organisations to plan and make informed decisions as they navigate the ever-evolving market landscape. Patient-centred healthcare remains a driver of industry strategies. Research firms can assist organisations in grasping the perspectives of patients, preferences for care, access difficulties, and patient satisfaction levels. These insights can help shape healthcare solutions to meet the demands and expectations of patients. Data analytics is becoming a vital tool for healthcare organisations to enhance their performance. Market research companies use both quantitative and qualitative research techniques, along with sophisticated analytical tools, to deliver insights that can be applied to drive action. Data-driven decision-making helps to be more accurate and confident in business planning. Market conditions may change with the introduction of regulatory changes and healthcare policy. Research companies track these activities and determine potential impacts on healthcare companies. Having access to information on time can enable businesses to react accordingly to the evolving needs. Detailed market assessments are frequently required for partnerships, mergers, acquisitions and investment decisions. Healthcare market research companies offer impartial information that helps in due diligence and strategic assessments. These services provide a better insight into opportunities and related risks across Europe. ...Read more

Building Resilient Animal Health Supply Chains for Modern Veterinary Care

Modern veterinary care depends on a steady and reliable flow of medicines, vaccines, diagnostics and equipment. Animal health supply chains have become more complex as demand grows across companion animals, livestock and emerging care segments. Disruptions in sourcing, manufacturing or distribution can quickly impact clinical outcomes. This has pushed providers and suppliers to rethink how resilience is built into every stage of the supply network. A resilient supply chain begins with visibility. Veterinary networks now rely on digital systems that track inventory movement in real time. These systems help clinics anticipate shortages and adjust procurement before issues escalate. Better forecasting also reduces waste, especially for temperaturesensitive products. With clearer data flows, decision makers gain the confidence to act early rather than react late. Strong supplier relationships are another cornerstone of resilience. Veterinary organizations are moving away from singlesource dependency and building diversified supplier bases. This reduces exposure to disruptions caused by regional challenges or production delays. Collaboration with manufacturers also improves communication around lead times and product availability. When partners share information openly, the entire ecosystem becomes more stable. How Can Veterinary Supply Chains Adapt to Disruption? Adaptability depends on flexibility in logistics and operations. Distribution models are shifting toward regional hubs that can respond faster to local demand changes. This reduces transit time and allows quicker replenishment. Cold chain management has also improved with better packaging and monitoring tools. These advancements ensure that sensitive products maintain quality even during unexpected delays. Technology is playing a growing role in strengthening adaptability. Automation in warehouses speeds up order processing and reduces human error. Artificial intelligence supports demand planning by identifying patterns that may not be visible through traditional methods. These tools enable supply chains to adjust dynamically as conditions change. Workforce readiness is equally important. Skilled professionals who understand both veterinary needs and supply chain dynamics are essential for smooth operations. Training programs are helping teams handle disruptions with confidence and maintain service continuity. When people are prepared, the system as a whole becomes more resilient. What Role Does Collaboration Play in LongTerm Resilience? Collaboration across stakeholders creates a more connected and responsive supply network. Veterinary clinics, distributors, manufacturers and regulators are working together to address shared challenges. This includes improving regulatory processes that affect product movement and availability. Streamlined procedures reduce delays and ensure faster access to critical supplies. Information sharing is central to effective collaboration. Platforms that allow real-time communication between stakeholders help align expectations and reduce uncertainty. This transparency builds trust and encourages proactive problem-solving. It also supports coordinated responses during emergencies or supply shocks. Sustainability is emerging as a key factor in long-term resilience. Environmentally responsible practices such as optimized transport routes and reduced packaging waste contribute to both efficiency and stability. Ethical sourcing also strengthens supplier relationships and ensures consistent quality. By aligning operational goals with sustainability principles, supply chains become more robust and futureready. Building resilient animal health supply chains requires a balanced approach that combines technology partnerships and skilled people. As veterinary care continues to evolve, these supply networks must remain agile and dependable. A resilient system not only supports clinical excellence but also ensures that animals receive timely and effective care in every situation. ...Read more

Former University of Cambridge Department Head of Estates Joins Anenta to Establish and Run New Facilities Management Division

Anenta, one of the UK’s leading healthcare waste management service providers, has appointed Karen King, former Department Head of Estates at the University of Cambridge, as Head of its newly formed Facilities Management (FM) division. King joins the business which supports over 20,000 public and private sector sites throughout England, including GPs, Pharmacies and hospitals.  King, who was previously responsible for the University of Cambridge Department of Physics portfolio of buildings – including the new world-class Ray Dolby Centre – will develop Anenta FM Services leading its delivery of soft and hard FM services to new and existing customers. Launching first in London and then Cambridgeshire, before rolling out nationally, Anenta FM Services is committed to working with local specialist companies to deliver a faster response, better local knowledge, greater flexibility, and more competitive pricing. This approach is designed to deliver a more sustainable solution that minimises environmental impact while keeping more money in the local economy.  Anenta's specialist FM team will help it stand out in the sector by identifying and removing unnecessary services that customers frequently pay for as part of dated, legacy contracts.  Utilising its proprietary technology, bespoke FM solutions, expertise in best practice, compliance and statutory requirements, Anenta FM services aims to shake up the market. This will be delivered by improving service levels and identifying savings that can be returned to clients. As part of this approach, Anenta FM services will implement contracts where whole-life costs are factored in, including mobilisation, planned preventative maintenance, reactive repairs and lifecycle savings.  Providing greater transparency and delivering reduced business disruption, this approach will ensure customer equipment lasts longer, resulting in fewer breakdowns or expensive emergency repairs. It also means that business-critical equipment will be replaced at the right time, avoiding the likelihood of catastrophic failure. Hard FM services provided by Anenta FM Services will include electrical, mechanical, plumbing and heating maintenance, along with fire safety, emergency lighting and gas servicing. Its soft FM offering will encompass cleaning, waste management, grounds maintenance, pest control, window cleaning, furniture purchase, office moves and health and safety, aligning services with the needs of the building. Commenting on her appointment, Karen King, new Head of Anenta’s Facilities Management division, said: “We aim to make an immediate impact by doing things differently at Anenta. Our focus will be on delivering transparent solutions that factor in whole-life costs as well as necessary work and maintenance. Unlike competitors that tender for contracts based on lowest headline prices, which fail to factor in real world costs, we’ll deliver tenders based on true lifetime value.  “By working with specialist local businesses overseen by our team of FM management experts, we believe we can build better solutions, improving levels of service, and lowering customer costs compared to the big national players.”  William Cunningham-Davis, Anenta’s Director of Development & Partnerships, added: “Karen brings with her many years of industry expertise and knowledge allowing us to build an FM solution that's both agile and highly effective. Combined with our technology and sector know-how – which has already saved our clients over £13m, plus a further £35m through efficiency improvements – we believe we can shake up the sector and give customers a better and more comprehensive service.” An industry expert, Karen King has served on the Premises and Facilities Management Editorial Advisory Board for five years and is part of the judging panel for the PFM awards. For more information about Anenta FM Services email karen.king@anenta.com , or call Karen King direct on 07861390821. Visit https://www.anentawaste.com/sectors/facilities-management-estates-services/ for full details. ...Read more

The Evolving Role of The Imaging Director

When I first entered leadership in radiology, being a successful imaging director was largely about being a strong clinical and operational leader. You needed to understand your modalities, manage your staff, maintain your equipment, control your budget, meet regulatory requirements, and make sure patients moved efficiently through the department. Those responsibilities have not gone away. If anything, they have become more complex. What has changed is everything that has been added to them. Today’s imaging director is still responsible for the clinical operation. But the role now reaches into information technology, workforce strategy, capital planning, construction, finance, regulatory compliance, patient access, data analytics and increasingly, artificial intelligence. Decisions that once may have involved selecting a piece of imaging equipment can now require months of planning involving IT infrastructure, interfaces, cybersecurity, construction, service agreements, software licensing, data storage and integration with other hospital systems. Staffing is a good example of that evolution. Earlier in my career, staffing was not nearly the challenge it is today. There were more technologists available and competition for staff was significantly different. Today, particularly since COVID-19, we face technologist shortages while also adapting to a workforce looking for schedules that better fit their lives—four 10-hour shifts, three 12-hour shifts, Baylor shifts and other alternatives. Technology has undergone an equally dramatic transformation. Imaging services is now one of the most technology-dependent areas of the hospital. Picture archiving and communication system (PACS) is only the beginning. Quality-control applications, analytics, advanced processing, AI, interfaces, servers, data storage and integration with the electronic medical record have become part of our daily environment. That means an imaging director no longer has the luxury of saying, “That’s an IT issue.” We do not have to be IT engineers, but we need to understand enough to ask the right questions. How will the system interface with PACS and the EMR? Where will the application reside? Who provides the server? How much storage will be required? What happens during downtime? What are the ongoing licensing and support costs? Even adding a single new imaging service demonstrates how involved the role has become. Consider implementing amyloid brain PET/CT imaging for Alzheimer’s disease evaluation. On the surface, it may sound as simple as developing a protocol and adding a new exam to the schedule. In reality, the imaging director has to understand the entire process from beginning to end. Do we have access to the appropriate radiopharmaceutical, and what purchasing or vendor agreements are required? Do we have the necessary software to process the study, and does that software need to be purchased, installed, interfaced, or integrated into the existing imaging environment? Are the technologists trained to perform and process the examination? Are the radiologists prepared to interpret it? How will the exam be built in the EMR and billing systems? Are the appropriate charges established, and do we understand the requirements necessary to obtain reimbursement? “Successful imaging leadership still comes down to people—supporting our teams, making thoughtful decisions and never losing sight of the patient at the center of it all.” A new service is not truly ready simply because we can acquire the images. We have to make sure we can perform it, process it, interpret it, charge for it, and get reimbursed for it. Missing any one of those pieces can mean investing significant time and money into a service that cannot function as intended. That is why today’s imaging director needs enough knowledge of technology, clinical operations, contracts, IT infrastructure, physician workflows and revenue cycle to see how all the pieces fit together. That understanding matters financially as well. I have inherited projects where significant expenses were overlooked during the initial planning. Few things are more difficult than returning to hospital leadership for additional funding after a project was approved based on what everyone believed was a complete cost. Understanding the technology behind the project has therefore become part of responsible financial leadership. A recent hospital acquisition demonstrated just how broad the imaging director’s role has become on an even larger scale. Our organization assumed responsibility for a small rural hospital and began transitioning it into an urgent care and diagnostic center. From an imaging perspective, that meant much more than assuming responsibility for another department. We had to transition employees into our processes and policies, establish new sites and cost centers within the EMR, upgrade software and storage, migrate imaging studies into PACS, review contracts and integrate the operation into a larger health system. The technology was only part of the challenge. Bringing employees into a new organization requires leadership. You cannot simply walk in and say, “This is how we do it now.” You need to understand their processes, recognize what they may already be doing well and determine whether some of their practices could improve the larger organization. Most importantly, people need to feel that they are becoming part of the team rather than simply being absorbed by it. Capital planning requires the same long-term perspective. I work from a five-year plan based on equipment age, functionality, emerging technology and potential new service lines that could benefit the communities we serve. Imaging equipment represents some of the largest capital investments a hospital makes, and replacing aging equipment can compete directly with opportunities to introduce new services. Even the best plan must remain flexible because an unexpected equipment failure can quickly take priority over planned capital spending. Patient access is another responsibility that extends well beyond scanner availability. Scheduling may be a patient’s first meaningful interaction with imaging services. Every imaging examination has different preparation requirements, clinical considerations, arrival times and expectations. Giving scheduling teams the knowledge and tools to communicate those differences correctly can directly influence the patient’s first impression of their imaging experience. Leading multiple locations adds yet another dimension. A director cannot be everywhere, which makes developing strong managers and supervisors essential. Those leaders need the ability to handle local issues while also knowing when something needs to be elevated. It also makes succession planning critical. If we advance in our own careers, we should not leave behind a department that was dependent upon us to succeed. Part of leadership is developing the people who can lead after us. Despite all of this complexity, my most important leadership lesson is to lead with a servant’s heart. Be willing to help. Treat people with respect. Make sure they know you have their back, and help them understand not only what decisions are being made, but why. When employees understand productivity, expenses, supply stewardship and how organizational performance affects the resources available to their department, they become partners in improvement rather than simply employees following instructions. Looking ahead, I expect enterprise imaging, automation and artificial intelligence to make the role even more complex. Radiologist shortages and greater reliance on teleradiology are already changing workflows. Technologies capable of identifying higher-risk studies and prioritizing radiologist worklists may become increasingly important in improving turnaround times and getting critical studies interpreted sooner. A successful imaging director today has to be more than a clinical and operational leader. At different moments, we are asked to think like a COO, CIO, construction manager, financial analyst, technology strategist and workforce strategist. The role has become more complicated, more technical and more strategic. But at its core, successful imaging leadership still comes down to people—supporting our teams, making thoughtful decisions and never losing sight of the patient at the center of it all. ...Read more
Healthcare Business Review APAC
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editorial@healthcarebusinessreview.com
  • salesus@healthcarebusinessreview.com
  • marketingus@healthcarebusinessreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Healthcare Business Review APAC. All rights reserved.

CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.healthcarebusinessreviewapac.com/news/ai-and-firstparty-data-transforms-pharma-customer-engagement-nwid-2574.html